<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01622257</url>
  </required_header>
  <id_info>
    <org_study_id>ASU6-2011</org_study_id>
    <nct_id>NCT01622257</nct_id>
  </id_info>
  <brief_title>Cavitation Ultrasound in Treatment of Patients With PCOS</brief_title>
  <official_title>Comparison of Cavitation Ultrasound, Metformin or the Combination of Both in Obese Women With Polycystic Ovary Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the current work was to compare the efficacy of cavitation ultrasound, metformin
      or combination of both in obese women with polycystic ovary syndrome (PCOS) regarding
      clinical pregnancy rate, ovulation rate, insulin resistance, serum testosterone level, lipid
      profile.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Polycystic ovary syndrome (PCOS) affects 5 to 10% of women of childbearing age and is the
      most common cause of anovulatory infertility. Common clinical manifestations include
      menstrual irregularities and signs of androgen excess such as hirsutism, acne, and alopecia.
      Metformin, a biguanide, is the most widely used drug for the treatment of type 2 diabetes
      worldwide. Its primary action is to inhibit hepatic glucose production, but it also increases
      the sensitivity of peripheral tissues to insulin. The increase in insulin sensitivity, which
      contributes to the efficacy of metformin in the treatment of diabetes, has also been shown in
      non diabetic women with the polycystic ovary syndrome.In women with PCOS, long-term treatment
      with metformin may increase ovulation, improve menstrual cyclicity, and reduce serum androgen
      levels; the use of metformin may also improve hirsutism. If published data on the effects of
      metformin in the prevention of diabetes can be extrapolated to women with the PCOS, then the
      drug may actually retard progression to glucose intolerance in affected women, as reported in
      a small, retrospective study. Ultrasonic vibrations spread in the form of a wave in medium
      such as a liquid or a solid. When the particles of an elastic medium are under ultrasonic
      vibration, they act continuously in only one direction. The lipolytic range of ultrasounds is
      30-70 Kilohertz (KHz), and the best effects are obtained in a range between30-35 KHz. The
      depth of the treatment in the tissues is generally2-3 cm, to avoid muscles involvement.
      Biological effects of ultrasounds on adipocytes are: micro-mechanical, thermal,
      micro-streaming and cavitation. Cavitation ultrasound means that ultrasounds produce an
      alternation of decompression and compression waves in a fluid media which progressively
      increase the tension of the adipocyte until it implodes and frees the emulsified fat. The aim
      of the current work was to compare the efficacy of cavitation ultrasound, metformin or
      combination of both in obese women with polycystic ovary syndrome (PCOS) regarding clinical
      pregnancy rate, ovulation rate, insulin resistance, serum testosterone level, lipid profile.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2011</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical Pregnancy Rate</measure>
    <time_frame>9 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ovulation Rate as Determined by Ultrasonographic Folliculometry and Luteal Serum Progesterone Assay.</measure>
    <time_frame>3 months</time_frame>
    <description>The Number of participants who had evidence of successful ovulation during the 3 months. Ovulation was diagnosed based on ultrasonographic folliculometry and/or luteal serum progesterone assay.Every month, folliculometry was done to count the number of antral follicles (AFC), follow follicular growth, measure dominant follicle diameter and detect occurrence of ovulation. a mid-luteal serum progesterone assay was done to confirm ovulation.
Ultrasound was performed serially till reaching preovulatory follicle(s of around 20 mm in diameter that then rupture to show a collapsed follicle in the same location with internal echoes consistent with its transformation to a corpus luteum. Progesterone assay was done using immulite 2000 apparatus chemiluminescent immunometric assay. Mid-luteal phase progesterone above 6 ng/mL was considered indicative of normal corpus. luteum function.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Insulin Resistance</measure>
    <time_frame>Baseline and 3 months</time_frame>
    <description>Change in Fasting insulin concentration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Serum Free Testosterone Level</measure>
    <time_frame>Baseline and 3 months</time_frame>
    <description>Change in serum free testosterone levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Lipid Profile</measure>
    <time_frame>Baseline and 3 months</time_frame>
    <description>Change in LDL levels was taken as the indicator of change in lipid profile</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">198</enrollment>
  <condition>PCOS</condition>
  <arm_group>
    <arm_group_label>Cavitation US</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cavitation ultrasound was done using ultrasonic cavitation machine 2 times per week for 3 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Metformin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Metformin oral tablets 500 mg were given three times daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cavitation US + metformin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Combination of both Cavitation US + Metformin</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cavitation US</intervention_name>
    <description>The areas with localized fat are treated 2 times per week for 3 months using Aesthetic cavitation via ultrasonic cavitation machine (Cavi SMART, South Korea, supplied with one piece cavitation probe of 40 KHz, 3-6 watt(W)/cm^2 adjustable, 60W with 20cm^2 active surface).</description>
    <arm_group_label>Cavitation US</arm_group_label>
    <other_name>Cavi SMART</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metformin</intervention_name>
    <description>Metformin hydrochloride (Glucophage 500 mg/tablet, Bristol-Myers Squibb, New York, USA). Medication is initiated in a step-up fashion every 5 days, from one tablet per day to three. This dose is maintained as tolerated throughout the 3 months of the study.</description>
    <arm_group_label>Metformin</arm_group_label>
    <other_name>Glucophage, Bristol-Myers Squibb, New York, USA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cavitation US + Metformin</intervention_name>
    <description>Combination of both Cavitation US + Metformin. the treatment duration lasts 3 months</description>
    <arm_group_label>Cavitation US + metformin</arm_group_label>
    <other_name>Glucophage + Cavi SMART</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Obese infertile polycystic ovarian syndrome (PCOS) women

        Exclusion Criteria:

          -  Women 40 years or older

          -  Women using fertility treatments, oral contraceptives or other confounding medications
             during the last 3 months

          -  Smokers or with history of general diseases like cardiovascular, liver, kidney or
             respiratory disease, diabetes, uncontrolled hypertension, or malignancy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mostafa I. Ibrahem, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Ain Shams University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohamed I. Ellaithy, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Lecturer Obstetics &amp; Gynecology Ain shams university faculty of medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ahmed K. Makled, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant professor of Obstetrics &amp; Gynecology Ain shams university faculty of medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ain shams university</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 18, 2012</study_first_submitted>
  <study_first_submitted_qc>June 18, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2012</study_first_posted>
  <results_first_submitted>October 14, 2012</results_first_submitted>
  <results_first_submitted_qc>December 26, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 7, 2013</results_first_posted>
  <last_update_submitted>March 9, 2017</last_update_submitted>
  <last_update_submitted_qc>March 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Mohamed Ellaithy</investigator_full_name>
    <investigator_title>Lecturer</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metformin</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>252 women were assessed for eligibility 54 women were excluded
Not meeting inclusion criteria (n=38)
Declined to participate (n=9)
Other reasons (n=7)</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Cavitation US</title>
          <description>Cavitation ultrasound was done using ultrasonic cavitation machine 2 times per week for 3 months</description>
        </group>
        <group group_id="P2">
          <title>Metformin</title>
          <description>Metformin oral tablets 500 mg were given three times daily for 3 months</description>
        </group>
        <group group_id="P3">
          <title>Cavitation US + Metformin</title>
          <description>Combination of both Cavitation US + Metformin</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="66"/>
                <participants group_id="P2" count="66"/>
                <participants group_id="P3" count="66"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="66"/>
                <participants group_id="P2" count="66"/>
                <participants group_id="P3" count="66"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Cavitation US</title>
          <description>Cavitation ultrasound was done using ultrasonic cavitation machine 2 times per week for 3 months</description>
        </group>
        <group group_id="B2">
          <title>Metformin</title>
          <description>Metformin oral tablets 500 mg were given three times daily for 3 months</description>
        </group>
        <group group_id="B3">
          <title>Cavitation US + Metformin</title>
          <description>Combination of both Cavitation US + Metformin</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="66"/>
            <count group_id="B2" value="66"/>
            <count group_id="B3" value="66"/>
            <count group_id="B4" value="198"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25.7" spread="4.5"/>
                    <measurement group_id="B2" value="26.1" spread="4.1"/>
                    <measurement group_id="B3" value="26.3" spread="5.2"/>
                    <measurement group_id="B4" value="26" spread="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="66"/>
                    <measurement group_id="B2" value="66"/>
                    <measurement group_id="B3" value="66"/>
                    <measurement group_id="B4" value="198"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Egypt</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66"/>
                    <measurement group_id="B2" value="66"/>
                    <measurement group_id="B3" value="66"/>
                    <measurement group_id="B4" value="198"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Duration of infertility</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.3" spread="1.5"/>
                    <measurement group_id="B2" value="3.4" spread="1.3"/>
                    <measurement group_id="B3" value="3.2" spread="1.3"/>
                    <measurement group_id="B4" value="3.3" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37.9" spread="4.9"/>
                    <measurement group_id="B2" value="36.7" spread="4.2"/>
                    <measurement group_id="B3" value="36.1" spread="5.2"/>
                    <measurement group_id="B4" value="36.9" spread="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Androgenic alopecia</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54"/>
                    <measurement group_id="B2" value="57"/>
                    <measurement group_id="B3" value="60"/>
                    <measurement group_id="B4" value="171"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Acne</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="26"/>
                    <measurement group_id="B4" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="43"/>
                    <measurement group_id="B3" value="40"/>
                    <measurement group_id="B4" value="131"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Seborrheic dermatitis</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="39"/>
                    <measurement group_id="B4" value="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="27"/>
                    <measurement group_id="B4" value="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Menstrual pattern</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Amenorrhea</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43"/>
                    <measurement group_id="B2" value="47"/>
                    <measurement group_id="B3" value="51"/>
                    <measurement group_id="B4" value="141"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oligomenorrhea</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Systolic blood pressure</title>
          <units>millimeters of mercury (mmHg)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="122.4" spread="10.1"/>
                    <measurement group_id="B2" value="121.9" spread="12.4"/>
                    <measurement group_id="B3" value="121.8" spread="12.3"/>
                    <measurement group_id="B4" value="122" spread="11.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diastolic blood pressure</title>
          <units>millimeters of mercury (mmHg)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="80.5" spread="8.2"/>
                    <measurement group_id="B2" value="81.6" spread="7.1"/>
                    <measurement group_id="B3" value="82.9" spread="7.8"/>
                    <measurement group_id="B4" value="81.7" spread="7.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Serum Follicle-stimulating Hormone (FSH)</title>
          <units>mIU/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6.1" spread="1.9"/>
                    <measurement group_id="B2" value="5.8" spread="2.2"/>
                    <measurement group_id="B3" value="6.6" spread="2.3"/>
                    <measurement group_id="B4" value="6.2" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Luteinizing Hormone (LH)</title>
          <units>mIU/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10.9" spread="1.1"/>
                    <measurement group_id="B2" value="10.7" spread="1.1"/>
                    <measurement group_id="B3" value="11.1" spread="1.8"/>
                    <measurement group_id="B4" value="10.9" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>LH/FSH ratio</title>
          <units>Ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.79" spread="0.7"/>
                    <measurement group_id="B2" value="1.85" spread="0.6"/>
                    <measurement group_id="B3" value="1.68" spread="0.6"/>
                    <measurement group_id="B4" value="1.77" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Total testosterone</title>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.84" spread="0.05"/>
                    <measurement group_id="B2" value="0.83" spread="0.04"/>
                    <measurement group_id="B3" value="0.83" spread="0.04"/>
                    <measurement group_id="B4" value="0.83" spread="0.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Free testosterone</title>
          <units>pg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.9" spread="2.07"/>
                    <measurement group_id="B2" value="3.8" spread="1.32"/>
                    <measurement group_id="B3" value="3.7" spread="1.72"/>
                    <measurement group_id="B4" value="3.8" spread="1.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fasting insulin</title>
          <units>µIU/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12.9" spread="6.4"/>
                    <measurement group_id="B2" value="12.5" spread="5.3"/>
                    <measurement group_id="B3" value="11.8" spread="4.1"/>
                    <measurement group_id="B4" value="12.4" spread="5.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fasting glucose</title>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="83.1" spread="21.4"/>
                    <measurement group_id="B2" value="79.4" spread="22.7"/>
                    <measurement group_id="B3" value="77.8" spread="22.1"/>
                    <measurement group_id="B4" value="80.1" spread="22.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fasting Glucose/Insulin Ratio (GIR)</title>
          <units>mg/mIU</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6.44" spread="0.8"/>
                    <measurement group_id="B2" value="6.35" spread="0.7"/>
                    <measurement group_id="B3" value="6.59" spread="0.7"/>
                    <measurement group_id="B4" value="6.46" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)</title>
          <description>Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)= Fasting insulin x Fasting glucose / 22.5</description>
          <units>HOMA score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.65" spread="1.01"/>
                    <measurement group_id="B2" value="2.45" spread="1.06"/>
                    <measurement group_id="B3" value="2.27" spread="0.99"/>
                    <measurement group_id="B4" value="2.46" spread="1.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Quantitative Insulin sensitivity Check Index (QUICKI)</title>
          <description>The quantitative insulin sensitivity check index (QUICKI) is derived using the inverse of the sum of the logarithms of the fasting insulin and fasting glucose:
1 / [(log(fasting insulin µU/mL) + log(fasting glucose mg/dL)]
µU/mL, microunits/milliliter; mg/dL, milligrams/deciliter.</description>
          <units>Index</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.33" spread="0.03"/>
                    <measurement group_id="B2" value="0.33" spread="0.04"/>
                    <measurement group_id="B3" value="0.34" spread="0.04"/>
                    <measurement group_id="B4" value="0.33" spread="0.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Total cholesterol</title>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="282.3" spread="32"/>
                    <measurement group_id="B2" value="273.4" spread="29.2"/>
                    <measurement group_id="B3" value="276.8" spread="30.5"/>
                    <measurement group_id="B4" value="277.2" spread="30.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Low-density lipoprotein (LDL)</title>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="129.7" spread="19.3"/>
                    <measurement group_id="B2" value="127.1" spread="20.4"/>
                    <measurement group_id="B3" value="122.6" spread="19.1"/>
                    <measurement group_id="B4" value="126.5" spread="19.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>High-density lipoprotein (HDL)</title>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="80.9" spread="11.2"/>
                    <measurement group_id="B2" value="77.8" spread="9.9"/>
                    <measurement group_id="B3" value="82.1" spread="10.8"/>
                    <measurement group_id="B4" value="80.4" spread="10.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Triglycerides (TGs)</title>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="204.9" spread="28.1"/>
                    <measurement group_id="B2" value="199.6" spread="22.4"/>
                    <measurement group_id="B3" value="208.4" spread="26.8"/>
                    <measurement group_id="B4" value="204.3" spread="25.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Waist to Hip Ratio (WHR)</title>
          <units>Ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.88" spread="0.7"/>
                    <measurement group_id="B2" value="0.89" spread="0.7"/>
                    <measurement group_id="B3" value="0.91" spread="0.8"/>
                    <measurement group_id="B4" value="0.89" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Total body fat percent</title>
          <units>Percentage</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43.2" spread="5.6"/>
                    <measurement group_id="B2" value="44.9" spread="6.2"/>
                    <measurement group_id="B3" value="45.6" spread="5.7"/>
                    <measurement group_id="B4" value="44.6" spread="5.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body fat mass</title>
          <units>Kilograms (kg)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37.7" spread="10.4"/>
                    <measurement group_id="B2" value="39.8" spread="11.2"/>
                    <measurement group_id="B3" value="41.1" spread="10.1"/>
                    <measurement group_id="B4" value="39.5" spread="10.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fat free mass</title>
          <units>Kilograms (kg)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50.8" spread="9.5"/>
                    <measurement group_id="B2" value="51.2" spread="9.1"/>
                    <measurement group_id="B3" value="51.2" spread="10.2"/>
                    <measurement group_id="B4" value="51.1" spread="9.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Abdominal fat mass</title>
          <units>Kilograms (kg)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6.8" spread="2.8"/>
                    <measurement group_id="B2" value="6.9" spread="3.2"/>
                    <measurement group_id="B3" value="7.1" spread="2.2"/>
                    <measurement group_id="B4" value="6.9" spread="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Emotion mean score</title>
          <description>The Emotions score consists of 8 items:
Depressed
Easily tired
Moody
Had low self-esteem
Fear of getting cancer
Worried
Being self-conscious
Late menstrual period
For each item there are seven rating options, 1 represents the greatest possible impairment, while 7 represents the least impairment.
A 2-week time frame was chosen for patients to describe their function. PCOSQ Emotions mean score = the average of the 8 items (Range=1-7) (PCOSQ, The Polycystic Ovary Syndrome Questionnaire)</description>
          <units>PCOSQ Emotion Score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.3" spread="1.4"/>
                    <measurement group_id="B2" value="4.9" spread="1.6"/>
                    <measurement group_id="B3" value="4.7" spread="1.7"/>
                    <measurement group_id="B4" value="4.6" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body hair mean score</title>
          <description>The Body Hair score consists of 5 items:
Visible hair on chin
Visible hair on upper lip
Visible hair on face
Embarrassment about excessive body hair
Visible body hair
For each item there are seven rating options, 1 represents the greatest possible impairment, while 7 represents the least impairment.
A 2-week time frame was chosen for patients to describe their function. PCOSQ Body hair mean score = the average of the 5 items (Range=1-7) (PCOSQ, The Polycystic Ovary Syndrome Questionnaire)</description>
          <units>PCOSQ Body hair Score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.4" spread="1.7"/>
                    <measurement group_id="B2" value="3.3" spread="1.9"/>
                    <measurement group_id="B3" value="3.7" spread="1.6"/>
                    <measurement group_id="B4" value="3.5" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight mean score</title>
          <description>The Weight score consists of 5 items:
Concerned about being overweight
Trouble dealing with your weight
Frustration in losing weight
Do not feel sexy because of weight
Difficulties staying at ideal weight
For each item there are seven rating options, 1 represents the greatest possible impairment, while 7 represents the least impairment.
A 2-week time frame was chosen for patients to describe their function. PCOSQ Weight mean score = the average of the 5 items (Range=1-7) (PCOSQ, The Polycystic Ovary Syndrome Questionnaire)</description>
          <units>PCOSQ Weight Score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.6" spread="1.4"/>
                    <measurement group_id="B2" value="2.4" spread="1.3"/>
                    <measurement group_id="B3" value="2.1" spread="1.5"/>
                    <measurement group_id="B4" value="2.4" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Menstrual problems mean score</title>
          <description>The Menstrual problems score consists of 4 items:
Headaches
Irregular menstrual periods
Abdominal Bloating
Menstrual cramps
For each item there are seven rating options, 1 represents the greatest possible impairment, while 7 represents the least impairment.
A 2-week time frame was chosen for patients to describe their function. PCOSQ Menstrual problems mean score = the average of the 4 items (Range=1-7) (PCOSQ, The Polycystic Ovary Syndrome Questionnaire)</description>
          <units>PCOSQ Menstrual problems Score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.6" spread="1.1"/>
                    <measurement group_id="B2" value="3.7" spread="1.1"/>
                    <measurement group_id="B3" value="3.9" spread="1.1"/>
                    <measurement group_id="B4" value="3.7" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Infertility mean score</title>
          <description>The Infertility score consists of 4 items:
Concerned with infertility problems
Fear of not having children
Feel lack of control over the situation
Sadness because of infertility problems
For each item there are seven rating options, 1 represents the greatest possible impairment, while 7 represents the least impairment.
A 2-week time frame was chosen for patients to describe their function. PCOSQ Infertility mean score = the average of the 4 items (Range=1-7) (PCOSQ, The Polycystic Ovary Syndrome Questionnaire)</description>
          <units>PCOSQ Infertility Score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.7" spread="1.02"/>
                    <measurement group_id="B2" value="3.6" spread="0.9"/>
                    <measurement group_id="B3" value="3.4" spread="1.1"/>
                    <measurement group_id="B4" value="3.6" spread="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Clinical Pregnancy Rate</title>
        <time_frame>9 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cavitation US</title>
            <description>Cavitation ultrasound was done using ultrasonic cavitation machine 2 times per week for 3 months</description>
          </group>
          <group group_id="O2">
            <title>Metformin</title>
            <description>Metformin oral tablets 500 mg were given three times daily for 3 months</description>
          </group>
          <group group_id="O3">
            <title>Cavitation US + Metformin</title>
            <description>Combination of both Cavitation US + Metformin</description>
          </group>
        </group_list>
        <measure>
          <title>Clinical Pregnancy Rate</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="66"/>
                <count group_id="O3" value="66"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ovulation Rate as Determined by Ultrasonographic Folliculometry and Luteal Serum Progesterone Assay.</title>
        <description>The Number of participants who had evidence of successful ovulation during the 3 months. Ovulation was diagnosed based on ultrasonographic folliculometry and/or luteal serum progesterone assay.Every month, folliculometry was done to count the number of antral follicles (AFC), follow follicular growth, measure dominant follicle diameter and detect occurrence of ovulation. a mid-luteal serum progesterone assay was done to confirm ovulation.
Ultrasound was performed serially till reaching preovulatory follicle(s of around 20 mm in diameter that then rupture to show a collapsed follicle in the same location with internal echoes consistent with its transformation to a corpus luteum. Progesterone assay was done using immulite 2000 apparatus chemiluminescent immunometric assay. Mid-luteal phase progesterone above 6 ng/mL was considered indicative of normal corpus. luteum function.</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cavitation US</title>
            <description>Cavitation ultrasound was done using ultrasonic cavitation machine 2 times per week for 3 months</description>
          </group>
          <group group_id="O2">
            <title>Metformin</title>
            <description>Metformin oral tablets 500 mg were given three times daily for 3 months</description>
          </group>
          <group group_id="O3">
            <title>Cavitation US + Metformin</title>
            <description>Combination of both Cavitation US + Metformin</description>
          </group>
        </group_list>
        <measure>
          <title>Ovulation Rate as Determined by Ultrasonographic Folliculometry and Luteal Serum Progesterone Assay.</title>
          <description>The Number of participants who had evidence of successful ovulation during the 3 months. Ovulation was diagnosed based on ultrasonographic folliculometry and/or luteal serum progesterone assay.Every month, folliculometry was done to count the number of antral follicles (AFC), follow follicular growth, measure dominant follicle diameter and detect occurrence of ovulation. a mid-luteal serum progesterone assay was done to confirm ovulation.
Ultrasound was performed serially till reaching preovulatory follicle(s of around 20 mm in diameter that then rupture to show a collapsed follicle in the same location with internal echoes consistent with its transformation to a corpus luteum. Progesterone assay was done using immulite 2000 apparatus chemiluminescent immunometric assay. Mid-luteal phase progesterone above 6 ng/mL was considered indicative of normal corpus. luteum function.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="66"/>
                <count group_id="O3" value="66"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Insulin Resistance</title>
        <description>Change in Fasting insulin concentration</description>
        <time_frame>Baseline and 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cavitation US</title>
            <description>Cavitation ultrasound was done using ultrasonic cavitation machine 2 times per week for 3 months</description>
          </group>
          <group group_id="O2">
            <title>Metformin</title>
            <description>Metformin oral tablets 500 mg were given three times daily for 3 months</description>
          </group>
          <group group_id="O3">
            <title>Cavitation US + Metformin</title>
            <description>Combination of both Cavitation US + Metformin</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Insulin Resistance</title>
          <description>Change in Fasting insulin concentration</description>
          <units>uIU/ml</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="66"/>
                <count group_id="O3" value="66"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.4" lower_limit="-2.61" upper_limit="-2.1"/>
                    <measurement group_id="O2" value="-1.1" lower_limit="-1.21" upper_limit="-0.9"/>
                    <measurement group_id="O3" value="-3.4" lower_limit="-3.74" upper_limit="-3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Serum Free Testosterone Level</title>
        <description>Change in serum free testosterone levels</description>
        <time_frame>Baseline and 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cavitation US</title>
            <description>Cavitation ultrasound was done using ultrasonic cavitation machine 2 times per week for 3 months</description>
          </group>
          <group group_id="O2">
            <title>Metformin</title>
            <description>Metformin oral tablets 500 mg were given three times daily for 3 months</description>
          </group>
          <group group_id="O3">
            <title>Cavitation US + Metformin</title>
            <description>Combination of both Cavitation US + Metformin</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Serum Free Testosterone Level</title>
          <description>Change in serum free testosterone levels</description>
          <units>pg/ml</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="66"/>
                <count group_id="O3" value="66"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.4" lower_limit="-0.44" upper_limit="-0.36"/>
                    <measurement group_id="O2" value="-0.2" lower_limit="-0.22" upper_limit="-0.18"/>
                    <measurement group_id="O3" value="-0.6" lower_limit="-0.65" upper_limit="-0.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Lipid Profile</title>
        <description>Change in LDL levels was taken as the indicator of change in lipid profile</description>
        <time_frame>Baseline and 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cavitation US</title>
            <description>Cavitation ultrasound was done using ultrasonic cavitation machine 2 times per week for 3 months</description>
          </group>
          <group group_id="O2">
            <title>Metformin</title>
            <description>Metformin oral tablets 500 mg were given three times daily for 3 months</description>
          </group>
          <group group_id="O3">
            <title>Cavitation US + Metformin</title>
            <description>Combination of both Cavitation US + Metformin</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Lipid Profile</title>
          <description>Change in LDL levels was taken as the indicator of change in lipid profile</description>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="66"/>
                <count group_id="O3" value="66"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-10.2" lower_limit="-11.08" upper_limit="-9.32"/>
                    <measurement group_id="O2" value="-8.9" lower_limit="-9.78" upper_limit="-8.02"/>
                    <measurement group_id="O3" value="-20.9" lower_limit="-22.9" upper_limit="-18.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Cavitation US</title>
          <description>Cavitation ultrasound was done using ultrasonic cavitation machine 2 times per week for 3 months</description>
        </group>
        <group group_id="E2">
          <title>Metformin</title>
          <description>Metformin oral tablets 500 mg were given three times daily for 3 months</description>
        </group>
        <group group_id="E3">
          <title>Cavitation US + Metformin</title>
          <description>Combination of both Cavitation US + Metformin</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="66"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1.52</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="66"/>
                <counts group_id="E3" subjects_affected="19" subjects_at_risk="66"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastrointestinal upset</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" events="34" subjects_affected="11" subjects_at_risk="66"/>
                <counts group_id="E3" events="31" subjects_affected="9" subjects_at_risk="66"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Generalized malaise</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" events="19" subjects_affected="4" subjects_at_risk="66"/>
                <counts group_id="E3" events="17" subjects_affected="3" subjects_at_risk="66"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Localized reaction</sub_title>
                <counts group_id="E1" events="19" subjects_affected="9" subjects_at_risk="66"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E3" events="23" subjects_affected="7" subjects_at_risk="66"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Moustafa Ibrahim</name_or_title>
      <organization>Assistant professor of Obstetrics &amp; Gynecology, Ain-shams faculty of medicine</organization>
      <phone>00201001955996</phone>
      <email>mi_monem@yahoo.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

